Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D. J. Kuhn
Drug Resistance to Inhibitors of the Human Double Minute-2 E3 Ligase Is Mediated by Point Mutations of P53, but Can Be Overcome With the P53 Targeting Agent RITA
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Resistance to PARP Inhibitors by SLFN11 Inactivation Can Be Overcome by ATR Inhibition
Oncotarget
Oncology
Mutations of P53 Gene Can Be Detected in the Plasma of Patients With Large Bowel Carcinoma
Journal of Clinical Pathology
Medicine
Forensic Medicine
Pathology
P53 Gene Mutations Are Uncommon but P53 Is Commonly Expressed in Anaplastic Large-Cell Lymphoma
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Targeting Efflux Pumps to Overcome Antifungal Drug Resistance
Future Medicinal Chemistry
Drug Discovery
Molecular Medicine
Pharmacology
RITA (Reactivating P53 and Inducing Tumor Apoptosis) Is Efficient Against TP53 Abnormal Myeloma Cells Independently of the P53 Pathway
BMC Cancer
Cancer Research
Oncology
Genetics
Wild-Type P53-Mediated Induction of Ratmdr1bExpression by the Anticancer Drug Daunorubicin
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Transporter and Lysosomal Mediated (Multi)drug Resistance to Tyrosine Kinase Inhibitors and Potential Strategies to Overcome Resistance
Cancers
Cancer Research
Oncology
Molecular Mechanisms of Functional Rescue Mediated by P53 Tumor Suppressor Mutations
Biophysical Chemistry
Organic Chemistry
Biochemistry
Biophysics
Ablation of Key Oncogenic Pathways by RITA-Reactivated P53 Is Required for Efficient Apoptosis
Cancer Cell
Cancer Research
Oncology
Cell Biology
